Cited by 91Nonmelanoma Skin Cancer StudiesCutaneous Melanoma Detection and ManagementCancer and Skin Lesions

Understanding Mohs Micrographic Surgery

Tolkachjov, Stanislav N., Brodland, David G., Coldiron, Brett M., Fazio, Michael J., Hruza, George J., Roenigk, Randall K., Rogers, Howard W., Zitelli, John A. +2 more·2017·Mayo Clinic Proceedings

Abstract

The incidence and diagnosis of cutaneous malignancies are steadily rising. In addition, with the aging population and increasing use of organ transplant and immunosuppressive medications, subsets of patients are now more susceptible to skin cancer. Mohs micrographic surgery (MMS) has become the standard of care for the treatment of high-risk nonmelanoma skin cancers and is increasingly used to treat melanoma. Mohs micrographic surgery has the highest cure rates, spares the maximal amount of normal tissue, and is cost-effective for the treatment of cutaneous malignancies. As in other medical fields, appropriate use criteria were developed for MMS and have become an evolving guideline for determining which patients and tumors are appropriate for referral to MMS. Patients with cutaneous malignancies often require multidisciplinary care. With the changing landscape of medicine and the rapidly increasing incidence of skin cancer, primary care providers and specialists who do not commonly manage cutaneous malignancies will need to have an understanding of MMS and its role in patient care. This review better familiarizes the medical community with the practice of MMS, its utilization and capabilities, differences from wide excision and vertical section pathology, and cost-effectiveness, and it guides practitioners in the process of appropriately evaluating and determining when patients with skin cancer might be appropriate candidates for MMS.

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2017.04.009

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mohs micrographic surgery evaluates 100% of the surgical margins.

    “MMS has the highest cure rates in the treatment of cutaneous carcinomas, as it evaluates 100% of the surgical margins, whereas the wide local excision technique assesses about 1% of the margins by”
  • Wide local excision assesses about 1% of the surgical margins.

    “MMS has the highest cure rates in the treatment of cutaneous carcinomas, as it evaluates 100% of the surgical margins, whereas the wide local excision technique assesses about 1% of the margins by”
  • Mohs micrographic surgery has the highest cure rates in the treatment of cutaneous carcinomas.

    “MMS has the highest cure rates in the treatment of cutaneous carcinomas, as it evaluates 100% of the surgical margins, whereas the wide local excision technique assesses about 1% of the margins by”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tolkachjov, S. N., Brodland, D. G., Coldiron, B. M., Fazio, M. J., Hruza, G. J., Roenigk, R. K., Rogers, H. W., Zitelli, J. A., Winchester, D. S., & Harmon, C. B.
Affiliations
  • Dallas Surgical Group (US)
  • University of Pittsburgh Medical Center (US)
  • University of Cincinnati (US)
  • Saint Louis University (US)
  • Mayo Clinic (US)
  • Advanced Dermatology (US)
Corresponding author
Tolkachjov, Stanislav N.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2017-08
Volume
92
Issue
8
Pages
1261-1271
ISSN
0025-6196 (ISSN-L)
OpenAlex
W2739894312
Cited by
91
References
94
Citations by year
2026: 8 · 2025: 10 · 2024: 8 · 2023: 9 · 2022: 15 · 2021: 14 · 2020: 18 · 2019: 4 · 2018: 4
FWCI
0.94
Type
journal article
Language
en
Open access
closed
Locations
  • Mayo Clinic Proceedings (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Dermatology › Cancer and Skin Lesions
Keywords
Mohs micrographic surgery, skin cancer, non-melanoma skin cancer, melanoma, appropriate use criteria, wide local excision, cost-effectiveness, multidisciplinary care, immunocompromised patients, primary care providers
MeSH terms
Carcinoma, Squamous Cell, Cost-Benefit Analysis, Humans, Melanoma, Neoplasm Recurrence, Local, Skin Neoplasms, Mohs Surgery, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review